
- Oncology NEWS International Vol 4 No 4
- Volume 4
- Issue 4
Cancer Gaining on Heart Disease in Some Parts of the World
WASHINGTON--According to the National Center for Health Statistics (NCHS), cancer now rivals or surpasses heart disease as the leading cause of death in several European countries and parts of Asia and Latin America. The new report is the most comprehensive look at international death rates ever undertaken by the NCHS. It compares age-adjusted death rates from 41 industrialized countries from 1955 through 1991.
WASHINGTON--According to the National Center for Health Statistics(NCHS), cancer now rivals or surpasses heart disease as the leadingcause of death in several European countries and parts of Asiaand Latin America. The new report is the most comprehensive lookat international death rates ever undertaken by the NCHS. It comparesage-adjusted death rates from 41 industrialized countries from1955 through 1991.
The United States has the lowest death rate from stroke in theindustrialized world for males and among the lowest for females.It also has significantly reduced deaths from heart disease. Onthe other hand, smoking-related lung cancer rates for US womenare among the highest for developed countries.
In the United States, heart disease remains the number 1 killer,with an age-adjusted death rate of 144.3 per 100,000 populationin 1992, followed by cancer at 133.1. The narrowing gap stemsprimarily from sharp declines in cardiovascular deaths, ratherthan increases in cancer deaths.
Although cancer deaths declined in this country by 1% from 1991to 1992, a larger fall was seen in heart disease (2.6%). Heartdisease saw a dramatic decline of 27.7% from 1979 to 1992, comparedwith a 1.8% overall increase in cancer deaths, according to aseparate NCHS report.
Articles in this issue
over 30 years ago
First Results of Avicidin Trialsover 30 years ago
Chemo Patients Often Develop Menstrual Irregularitiesover 30 years ago
Growth Factor Receptor Blockade Moving From Laboratory to Clinicover 30 years ago
Controlled-Release AZT Gets FDA Go-Ahead for New Drug Investigationover 30 years ago
Vinorelbine Plus Chemo Promising in Advanced Diseaseover 30 years ago
Bone Substudy a Part of Tamoxifen Prevention Trialover 30 years ago
Ultrasound Breast Screens Useful in Selected Womenover 30 years ago
New Roles Forecast for Endocrine Therapyover 30 years ago
Antisense Drug Against BCL-2 Effective in Animal Cancer Modelsover 30 years ago
Anticancer Drugs From Zeneca in Regulatory Phase of DevelopmentNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.